Invention Grant
- Patent Title: Modified pyrazine derivatives and uses thereof
- Patent Title (中): 改性吡嗪衍生物及其用途
-
Application No.: US13140107Application Date: 2009-12-17
-
Publication No.: US08697033B2Publication Date: 2014-04-15
- Inventor: Amruta Poreddy , William L. Neumann
- Applicant: Amruta Poreddy , William L. Neumann
- Applicant Address: US MO St. Louis
- Assignee: Medibeacon, LLC
- Current Assignee: Medibeacon, LLC
- Current Assignee Address: US MO St. Louis
- Agent Dennis A. Bennett; Gale W. Starkey
- International Application: PCT/US2009/068463 WO 20091217
- International Announcement: WO2010/078028 WO 20100708
- Main IPC: A61K49/00
- IPC: A61K49/00 ; A61P13/12 ; A61P13/10 ; C07D241/20 ; A61K31/4965

Abstract:
In some embodiments, the invention provides modified pyrazine derivatives containing a central pyrazine ring with two secondary amine groups attached directly to the central pyrazine ring and two amino carbonyl groups attached directly to the central pyrazine ring. The secondary amine groups are terminated by alkyl groups containing from 1 to 6 carbons. The amino carbonyl groups can be terminated by a wide range of substituents including, but not limited to, alkyl and alkylene groups, polyether groups, including poly(ethylene glycol) groups, secondary and tertiary amine groups, polyhydroxylated alkyl groups, amino carbonyl groups, amino thioketone groups, and combinations thereof. In some embodiments, the invention provides modified pyrazine derivatives useful as optical agents in a wide variety of biomedical imaging procedures, including diagnostic and imaging procedures. In an embodiment, for example, modified pyrazine derivatives are provided which are useful in monitoring organ and system functioning, for example in monitoring renal system functioning.
Public/Granted literature
- US20110250140A1 Modified Pyrazine Derivatives and Uses Thereof Public/Granted day:2011-10-13
Information query